N/A
Manufactured by Haleon US Holdings LLC
488 FDA adverse event reports analyzed
Last updated: 2026-04-15
WITCH HAZEL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Haleon US Holdings LLC. The most commonly reported adverse reactions for WITCH HAZEL include DRUG INEFFECTIVE, HEADACHE, NAUSEA, ERYTHEMA, RECTAL HAEMORRHAGE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for WITCH HAZEL.
Out of 163 classified reports for WITCH HAZEL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 488 FDA FAERS reports that mention WITCH HAZEL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, HEADACHE, NAUSEA, ERYTHEMA, RECTAL HAEMORRHAGE, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Haleon US Holdings LLC in connection with WITCH HAZEL. Always verify the specific product and NDC with your pharmacist.